TrialScope buys Deloitte trial tech assets; Lilly steps up data transparency policy;

> TrialScope secured new investment and bought clinical trial technology assets from Deloitte. News

> Eli Lilly ($LLY) updated its clinical trial data sharing policy. Release

> The FDA began looking for a contractor to help revamp its IT portfolio. Article

> Bioinformatics firm MedGenome raised $4 million to turn India's genetic homogeneity into health insights. Release

> A partnership with WHO boosted the size of TrialReach's clinical trials database. Piece

> The University of Kansas received a $19 million NIH grant, some of which will go toward research into bioinformatics. Aricle

> Techorizon will introduce a suite of eClinical technologies at DIA. Release

> Elsevier will publish an open-access journal on computational biology. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.